Literature DB >> 10323794

Direct to consumer advertising of prescription drugs. An idea whose time should not come.

J R Hoffman, M Wilkes.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10323794      PMCID： PMC1115695          DOI： 10.1136/bmj.318.7194.1301

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Are patients more satisfied when they receive a prescription? The effect of patient expectations in general practice.

Authors:  W Himmel; E Lippert-Urbanke; M M Kochen
Journal:  Scand J Prim Health Care       Date:  1997-09       Impact factor: 2.581

2.  The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

Authors:  J P Orlowski; L Wateska
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

3.  Pharmaceutical advertisements in leading medical journals: experts' assessments.

Authors:  M S Wilkes; B H Doblin; M F Shapiro
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

4.  Pushing ethical pharmaceuticals direct to the public.

Authors: 
Journal:  Lancet       Date:  1998-03-28       Impact factor: 79.321

5.  Direct-to-consumer prescription drug advertising builds bridges between patients and physicians.

Authors:  A F Holmer
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

6.  The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey.

Authors:  N Britten; O Ukoumunne
Journal:  BMJ       Date:  1997-12-06

7.  Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? Characteristics of materials distributed by drug companies: four points of view.

Authors:  S M Wolfe
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

8.  Thyroid storm.

Authors:  D Rennie
Journal:  JAMA       Date:  1997-04-16       Impact factor: 56.272

9.  The accuracy of drug information from pharmaceutical sales representatives.

Authors:  M G Ziegler; P Lew; B C Singer
Journal:  JAMA       Date:  1995-04-26       Impact factor: 56.272

Review 10.  Characteristics of materials distributed by drug companies. An evaluation of appropriateness.

Authors:  D Stryer; L A Bero
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128
  10 in total
  8 in total

1.  Adolescent mental health and risky sexual behaviour. Young people need health care that covers psychological, sexual, and social areas.

Authors:  D L Bennett; A Bauman
Journal:  BMJ       Date:  2000-07-29

2.  Direct-to-consumer advertising of prescription drugs.

Authors:  R L Kravitz
Journal:  West J Med       Date:  2000-10

Review 3.  Benefits and harms of direct to consumer advertising: a systematic review.

Authors:  S Gilbody; P Wilson; I Watt
Journal:  Qual Saf Health Care       Date:  2005-08

4.  The Drug Facts Box: Improving the communication of prescription drug information.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-13       Impact factor: 11.205

5.  Medical Practice in the Twenty-First Century - What, if anything, will doctors be doing?

Authors:  Des Gorman
Journal:  Sultan Qaboos Univ Med J       Date:  2008-11

6.  Patients and computers as reminders to screen for diabetes in family practice. Randomized-controlled trial.

Authors:  Tim Kenealy; Bruce Arroll; Keith J Petrie
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

7.  Factors affecting physicians' responses to patients' requests for antidepressants: focus group study.

Authors:  Aleksey Tentler; Jordan Silberman; Debora A Paterniti; Richard L Kravitz; Ronald M Epstein
Journal:  J Gen Intern Med       Date:  2007-11-07       Impact factor: 5.128

8.  Use of complementary/alternative therapies by women with advanced-stage breast cancer.

Authors:  Joannie Shen; Ronald Andersen; Paul S Albert; Neil Wenger; John Glaspy; Melissa Cole; Paul Shekelle
Journal:  BMC Complement Altern Med       Date:  2002-08-13       Impact factor: 3.659
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.